Helicobacter pylori cag pathogenicity island-positive strains induce syndecan-4 expression in gastric epithelial cells |
| |
Authors: | Ana Magalhã es,Nuno T. Marcos,Ana S. Carvalho,Leonor David,Cé u Figueiredo,Joana Bastos,Guido David,& Celso A. Reis |
| |
Affiliation: | Institute of Molecular Pathology and Immunology, University of Porto (IPATIMUP), Porto, Portugal;;Medical Faculty, University of Porto, Porto, Portugal;;Institute of Public Health, University of Porto, Porto, Portugal;and;Department of Human Genetics, Katholieke University of Leuven, Leuven, Belgium |
| |
Abstract: | Helicobacter pylori is recognized as the main cause of gastritis and is associated with gastric carcinogenesis. Syndecan-4 represents the major source of heparan sulfate (HS) in the gastric cells. HS proteoglycans expressed on the cell surface constitute targets for H. pylori at the early stage of infection. The aim of this study was to determine whether H. pylori induction of syndecan-4 expression is affected by the virulence characteristics of the infecting strain, namely the cytotoxic-associated gene ( cag ) pathogenicity island (PAI). We observed that individuals infected with highly pathogenic H. pylori strains express syndecan-4 in the foveolar epithelium of the gastric mucosa. The association between the cag PAI status of the infecting strain and syndecan-4 expression was further demonstrated by infection of gastric epithelial cell lines with a panel of cag PAI+ and cag PAI− H. pylori strains, showing that expression of syndecan-4 was significantly increased in response to infection with the highly pathogenic strains. Moreover, infection of gastric cells with cag A and cag E mutant strains further confirmed that syndecan-4 induction is dependent on an intact cag PAI. The present study shows that highly pathogenic H. pylori strains induce syndecan-4 expression, both in human gastric mucosa and in gastric cell lines, in a cag PAI-dependent manner. |
| |
Keywords: | Helicobacter pylori cag pathogenicity island syndecan-4 heparan sulfate gastric disease |
|
|